Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

RUXIENCE

RITUXIMAB-PVVR

Standard Dose
500MG/50ML(10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview RUXIENCE is listed in Drugs@FDA under application 761103 (BLA).

Marketing status: Prescription Active ingredient RITUXIMAB-PVVR Form and strength INJECTABLE;INJECTION - 500MG/50ML(10MG/ML) Sponsor PFIZER INC Submission history Latest submission status date: 2025-06-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview RUXIENCE is listed in Drugs@FDA under application 761103 (BLA). Marketing status: Prescription Active ingredient RITUXIMAB-PVVR Form and strength INJECTABLE;INJECTION - 500MG/50ML(10MG/ML) Sponsor PFIZER INC Submission history Latest submission status date: 2025-06-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
RUXIENCE (RITUXIMAB-PVVR) | Drug Monograph | MedicHelpline